When did OS Therapies report Q4 2024 earnings?

OS Therapies (OSTX) reported Q4 2024 earnings on March 31, 2025 before market open.

What were OS Therapies's Q4 2024 revenue and EPS?

OS Therapies reported diluted EPS of $-0.24 for Q4 2024.

EPS missed the consensus estimate of $-0.14 by $0.10.

You can read the 10-K periodic report (0001213900-25-026238) directly on SEC EDGAR. The filing index links above go to sec.gov.

Reported March 31, 2025 · Before market open

EPS estimate-$0.14

Aug 17, 2026 (in a month)

Revenue estimate$511.0K

EPS estimate-$0.25

Q4 2024

Operating income-$3.0M-156%

Net income-$3.0M-104%

EPS (diluted)-$0.64+24.7%

Cash & equivalents$5.5M+14,095%

Total equity-$3.3M+86.4%

Total assets$5.5M+594%

Operating cash flow-$2.4M-173%

Q4 2024-$0.24Miss by $0.10

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

When did OS Therapies report Q4 2024 earnings?: OS Therapies (OSTX) reported Q4 2024 earnings on March 31, 2025 before market open.
What were OS Therapies's Q4 2024 revenue and EPS?: OS Therapies reported diluted EPS of $-0.24 for Q4 2024.
Did OS Therapies beat estimates in Q4 2024?: EPS missed the consensus estimate of $-0.14 by $0.10.
Where can I find OS Therapies's Q4 2024 SEC filings?: You can read the 10-K periodic report (0001213900-25-026238) directly on SEC EDGAR. The filing index links above go to sec.gov.